Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Breast Cancer

Free Subscription Articles published in Cancer Retrieve available abstracts of 134 articles: HTML format Text format

Single Articles

April 2012
1. LIN NU , Vanderplas A, Hughes ME, Theriault RL, et al
   Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.
   Cancer. 2012 Apr 27. doi: 10.1002/cncr.27581.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. MORRIS PG , Ulaner GA, Eaton A, Fazio M, et al
   Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
   Cancer. 2012 Apr 19. doi: 10.1002/cncr.27579.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. BREWSTER AM , Bedrosian I, Parker PA, Dong W, et al
   Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status.
   Cancer. 2012 Apr 19. doi: 10.1002/cncr.27574.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. KIM MM , Dawood S, Allen P, Sahin AA, et al
   Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer.
   Cancer. 2012 Apr 17. doi: 10.1002/cncr.27502.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. NIE F , Yang J, Wen S, An YL, et al
   Involvement of epidermal growth factor receptor overexpression in the promotion of breast cancer brain metastasis.
   Cancer. 2012 Apr 17. doi: 10.1002/cncr.27553.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. STOUT NL , Andrews K, Binkley JM, Schmitz KH, et al
   Stakeholder perspectives on dissemination and implementation of a prospective surveillance model of rehabilitation for breast cancer treatment.
   Cancer. 2012;118.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. CHEVILLE AL , Nyman JA, Pruthi S, Basford JR, et al
   Cost considerations regarding the prospective surveillance model for breast cancer survivors.
   Cancer. 2012;118.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. HARRIS SR , Schmitz KH, Campbell KL, McNeely ML, et al
   Clinical practice guidelines for breast cancer rehabilitation: Syntheses of guideline recommendations and qualitative appraisals.
   Cancer. 2012;118.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. CAMPBELL KL , Pusic AL, Zucker DS, McNeely ML, et al
   A prospective model of care for breast cancer rehabilitation: Function.
   Cancer. 2012;118.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. WINTERS-STONE KM , Schwartz AL, Hayes SC, Fabian CJ, et al
    A prospective model of care for breast cancer rehabilitation: Bone health and arthralgias.
    Cancer. 2012;118.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. DEMARK-WAHNEFRIED W , Campbell KL, Hayes SC
    Weight management and its role in breast cancer rehabilitation.
    Cancer. 2012;118.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. SCHMITZ KH , Prosnitz RG, Schwartz AL, Carver JR, et al
    Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.
    Cancer. 2012;118.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. BERGER AM , Gerber LH, Mayer DK
    Cancer-related fatigue: Implications for breast cancer survivors.
    Cancer. 2012;118.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. STUBBLEFIELD MD , McNeely ML, Alfano CM, Mayer DK, et al
    A prospective surveillance model for physical rehabilitation of women with breast cancer: Chemotherapy-induced peripheral neuropathy.
    Cancer. 2012;118.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. HAYES SC , Johansson K, Stout NL, Prosnitz R, et al
    Upper-body morbidity after breast cancer: Incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.
    Cancer. 2012;118.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. MCNEELY ML , Binkley JM, Pusic AL, Campbell KL, et al
    A prospective model of care for breast cancer rehabilitation: Postoperative and postreconstructive issues.
    Cancer. 2012;118.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. SCHMITZ KH , Speck RM, Rye SA, Disipio T, et al
    Prevalence of breast cancer treatment sequelae over 6 years of follow-up: The Pulling Through Study.
    Cancer. 2012;118.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. BINKLEY JM , Harris SR, Levangie PK, Pearl M, et al
    Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer.
    Cancer. 2012;118.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. GERBER LH , Stout NL, Schmitz KH, Stricker CT, et al
    Integrating a prospective surveillance model for rehabilitation into breast cancer survivorship care.
    Cancer. 2012;118.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. STOUT NL , Binkley JM, Schmitz KH, Andrews K, et al
    A prospective surveillance model for rehabilitation for women with breast cancer.
    Cancer. 2012;118.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. SCHMITZ KH , Stout NL, Andrews K, Binkley JM, et al
    Prospective evaluation of physical rehabilitation needs in breast cancer survivors: A call to action.
    Cancer. 2012;118.
    PubMed     Text format     Related articles   
    
    
    
    March 2012
22. PRINTZ C
    A case for annual mammography screening.
    Cancer. 2012;118:1473.
    PubMed     Text format     Related articles   
    
    
    
    
23. HOEFNAGEL LD , Moelans CB, Meijer SL, van Slooten HJ, et al
    Prognostic value of estrogen receptor alpha and progesterone receptor conversion in distant breast cancer metastases.
    Cancer. 2012 Mar 13. doi: 10.1002/cncr.27518.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2012
24. DAWOOD S , Lei X, Litton JK, Buchholz TA, et al
    Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer.
    Cancer. 2012 Feb 22. doi: 10.1002/cncr.27434.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. WONG IO , Tsang JW, Cowling BJ, Leung GM, et al
    Optimizing resource allocation for breast cancer prevention and care among Hong Kong Chinese women.
    Cancer. 2012 Feb 22. doi: 10.1002/cncr.27448.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. YANG M , Rajan S, Issa AM
    Cost effectiveness of gene expression profiling for early stage breast cancer: A decision-analytic model.
    Cancer. 2012 Feb 22. doi: 10.1002/cncr.27443.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. BAQUERO MT , Hanna JA, Neumeister V, Cheng H, et al
    Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer.
    Cancer. 2012 Feb 22. doi: 10.1002/cncr.27453.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. PRINTZ C
    Depression in Latina survivors of breast cancer affects preventive health screening.
    Cancer. 2012;118:869.
    PubMed     Text format     Related articles   
    
    
    
    January 2012
29. JAIN S , Coulter I, Mills P
    Reply to complementary medicine for fatigue and cortisol variability in breast cancer survivors.
    Cancer. 2012 Jan 26. doi: 10.1002/cncr.27421.
    PubMed     Text format     Related articles   
    
    
    
    
30. COYNE JC , Johansen C, Gorski D
    Complementary medicine for fatigue and cortisol variability in breast cancer survivors.
    Cancer. 2012 Jan 26. doi: 10.1002/cncr.27415.
    PubMed     Text format     Related articles   
    
    
    
    
31. MORROW PK , Murthy RK, Ensor JD, Gordon GS, et al
    An open-label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer.
    Cancer. 2012 Jan 26. doi: 10.1002/cncr.26730.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. PAXTON RJ , Phillips KL, Jones LA, Chang S, et al
    Associations among physical activity, body mass index, and health-related quality of life by race/ethnicity in a diverse sample of breast cancer survivors.
    Cancer. 2012 Jan 17. doi: 10.1002/cncr.27389.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. ISHITOBI M , Ohsumi S, Inaji H, Ohno S, et al
    Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: Risk factors of IBTR and validation of the M. D. Anderson Prognostic Index.
    Cancer. 2012 Jan 17. doi: 10.1002/cncr.27377.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. TAMAKI Y , Sato N, Homma K, Takabatake D, et al
    Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: Results of a multicenter study in Japan.
    Cancer. 2012 Jan 17. doi: 10.1002/cncr.26683.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. YI M , Liu P, Li X, Mittendorf EA, et al
    Comparative analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States.
    Cancer. 2012 Jan 3. doi: 10.1002/cncr.27399.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
36. ADAMS SA , Steck SE, Hebert JR
    Reply to differences in vitamin D status likely explain racial disparities in breast cancer mortality rates in the southeast.
    Cancer. 2011 Dec 27. doi: 10.1002/cncr.27383.
    PubMed     Text format     Related articles   
    
    
    
    
37. GRANT WB , Mascitelli L, Goldstein MR
    Differences in vitamin D status likely explain racial disparities in breast cancer mortality rates in the southeast.
    Cancer. 2011 Dec 27. doi: 10.1002/cncr.27374.
    PubMed     Text format     Related articles   
    
    
    
    
38. BOWER JE , Garet D, Sternlieb B, Ganz PA, et al
    Yoga for persistent fatigue in breast cancer survivors: A randomized controlled trial.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26702.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. SAKAKIBARA M , Fujimori T, Miyoshi T, Nagashima T, et al
    Aldehyde dehydrogenase 1-positive cells in axillary lymph node metastases after chemotherapy as a prognostic factor in patients with lymph node-positive breast cancer.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26725.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. HEINEY SP , Underwood SM, Tavaloki A, Adams SA, et al
    Randomized trial of therapeutic group by teleconference: African American women with breast cancer.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26676.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. MARKO NF , Xu Z, Gao T, Kattan MW, et al
    Predicting survival in women with breast cancer and brain metastasis: A nomogram outperforms current survival prediction models.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26716.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. PHILLIPS KM , Jim HS, Small BJ, Laronga C, et al
    Cognitive functioning after cancer treatment: A 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls.
    Cancer. 2011 Dec 12. doi: 10.1002/cncr.26432.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. NIIKURA N , Liu J, Hayashi N, Palla SL, et al
    Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases.
    Cancer. 2011 Dec 2. doi: 10.1002/cncr.26512.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
44. MURPHY CG , Mallam D, Stein S, Patil S, et al
    Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer.
    Cancer. 2011 Nov 15. doi: 10.1002/cncr.26654.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. BORGES VF , Schedin PJ
    Pregnancy-associated breast cancer: An entity needing refinement of the definition.
    Cancer. 2011 Nov 15. doi: 10.1002/cncr.26643.
    PubMed     Text format     Related articles   
    
    
    
    
46. GOEDENDORP MM , Andrykowski MA, Donovan KA, Jim HS, et al
    Prolonged impact of chemotherapy on fatigue in breast cancer survivors: A longitudinal comparison with radiotherapy-treated breast cancer survivors and noncancer controls.
    Cancer. 2011 Nov 15. doi: 10.1002/cncr.26226.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. PRINTZ C
    Bevacizumab recommendation highlights difficulties.
    Cancer. 2011;117:5025.
    PubMed     Text format     Related articles   
    
    
    
    
48. BERKEY CS , Tamimi RM, Rosner B, Frazier AL, et al
    Young women with family history of breast cancer and their risk factors for benign breast disease.
    Cancer. 2011 Nov 14. doi: 10.1002/cncr.26519.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. BUZDAR A , Vogel C, Schwartzberg L, Garin A, et al
    Randomized double-blind phase 2 trial of 3 doses of TAS-108 in patients with advanced or metastatic postmenopausal breast cancer.
    Cancer. 2011 Nov 1. doi: 10.1002/cncr.26419.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
50. LIVI L , Meattini I, Saieva C, Franzese C, et al
    Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer.
    Cancer. 2011 Oct 25. doi: 10.1002/cncr.26647.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. PEREZ EA , Spano JP
    Current and emerging targeted therapies for metastatic breast cancer.
    Cancer. 2011 Oct 17. doi: 10.1002/cncr.26356.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. MOULDER S , Gladish G, Ensor J, Gonzalez-Angulo AM, et al
    A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer.
    Cancer. 2011 Oct 17. doi: 10.1002/cncr.26571.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. MITTENDORF EA , Clifton GT, Holmes JP, Clive KS, et al
    Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: From US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
    Cancer. 2011 Oct 11. doi: 10.1002/cncr.26574.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. PALMER SC , Taggi A, Demichele A, Coyne JC, et al
    Is screening effective in detecting untreated psychiatric disorders among newly diagnosed breast cancer patients?
    Cancer. 2011 Oct 11. doi: 10.1002/cncr.26603.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. BRUFSKY AM , Harker WG, Beck JT, Bosserman L, et al
    Final 5-year results of Z-FAST trial: Adjuvant Zoledronic Acid Maintains Bone Mass in Postmenopausal Breast Cancer Patients Receiving Letrozole.
    Cancer. 2011 Oct 10. doi: 10.1002/cncr.26313.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. JUNG EJ , Santarpia L, Kim J, Esteva FJ, et al
    Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients.
    Cancer. 2011 Oct 5. doi: 10.1002/cncr.26565.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. PRINTZ C
    Test may help predict chemotherapy response and survival in breast cancer.
    Cancer. 2011;117:4339.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
58. ADAMS SA , Butler WM, Fulton J, Heiney SP, et al
    Racial disparities in breast cancer mortality in a multiethnic cohort in the Southeast.
    Cancer. 2011 Sep 27. doi: 10.1002/cncr.26570.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. BAYRAKTAR S , Gonzalez-Angulo AM, Lei X, Buzdar AU, et al
    Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer.
    Cancer. 2011 Sep 27. doi: 10.1002/cncr.26555.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. GREENLEE H , Kwan ML, Kushi LH, Song J, et al
    Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort.
    Cancer. 2011 Sep 27. doi: 10.1002/cncr.26526.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. RENNERT G , Lejbkowicz F, Cohen I, Pinchev M, et al
    MutYH mutation carriers have increased breast cancer risk.
    Cancer. 2011 Sep 22. doi: 10.1002/cncr.26506.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. HO A , Cordeiro P, Disa J, Mehrara B, et al
    Long-term outcomes in breast cancer patients undergoing immediate 2-stage expander/implant reconstruction and postmastectomy radiation.
    Cancer. 2011 Sep 14. doi: 10.1002/cncr.26521.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. KELLY PJ , Lin NU, Claus EB, Quant EC, et al
    Salvage stereotactic radiosurgery for breast cancer brain metastases: Outcomes and prognostic factors.
    Cancer. 2011 Sep 14. doi: 10.1002/cncr.26343.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. KIESS AP , McArthur HL, Mahoney K, Patil S, et al
    Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer.
    Cancer. 2011 Sep 1. doi: 10.1002/cncr.26484.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
65. SETTON J , Cody H, Tan L, Morrow M, et al
    Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.
    Cancer. 2011 Aug 31. doi: 10.1002/cncr.26504.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. ZHENG Y , Zhang J, Niu Q, Huo D, et al
    Novel germline PALB2 truncating mutations in African American breast cancer patients.
    Cancer. 2011 Aug 26. doi: 10.1002/cncr.26388.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. BLINDER VS , Patil S, Thind A, Diamant A, et al
    Return to work in low-income Latina and non-Latina white breast cancer survivors: A 3-year longitudinal study.
    Cancer. 2011 Aug 25. doi: 10.1002/cncr.26478.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. XU Z , Marko NF, Angelov L, Barnett GH, et al
    Impact of preexisting tumor necrosis on the efficacy of stereotactic radiosurgery in the treatment of brain metastases in women with breast cancer.
    Cancer. 2011 Aug 25. doi: 10.1002/cncr.26314.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. WU Y , Mittendorf EA, Kelten C, Tucker SL, et al
    Occult axillary lymph node metastasis do not have prognostic significance in early stage breast cancer.
    Cancer. 2011 Aug 25. doi: 10.1002/cncr.26458.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. HOFFMAN HJ , Laverda NL, Levine PH, Young HA, et al
    Having health insurance does not eliminate race/ethnicity-associated delays in breast cancer diagnosis in the District of Columbia.
    Cancer. 2011;117:3824-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. MORROW PK , Serna R, Broglio K, Pusztai L, et al
    Effect of CYP2D6 polymorphisms on breast cancer recurrence.
    Cancer. 2011 Aug 5. doi: 10.1002/cncr.26407.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. JAIN S , Pavlik D, Distefan J, Bruyere RR, et al
    Complementary medicine for fatigue and cortisol variability in breast cancer survivors: A Randomized Controlled Trial.
    Cancer. 2011 Aug 5. doi: 10.1002/cncr.26345.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
73. BAYRAKTAR S , Hernadez-Aya LF, Lei X, Meric-Bernstam F, et al
    Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.
    Cancer. 2011 Jul 28. doi: 10.1002/cncr.26439.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. PRINTZ C
    Lymph node study leads to changes in breast cancer treatment: A subset of patients do not have poorer survival when fewer lymph nodes are removed.
    Cancer. 2011;117:3061-2.
    PubMed     Text format     Related articles   
    
    
    
    
75. FOUAD T
    Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: A large population-based study.
    Cancer. 2011 Jul 15. doi: 10.1002/cncr.26397.
    PubMed     Text format     Related articles   
    
    
    
    
76. DAWOOD S , Cristofanilli M
    Reply to differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: A large population-based study.
    Cancer. 2011 Jul 15. doi: 10.1002/cncr.26386.
    PubMed     Text format     Related articles   
    
    
    
    
77. ENEWOLD L , Zhou J, McGlynn KA, Anderson WF, et al
    Racial variation in breast cancer treatment among department of defense beneficiaries.
    Cancer. 2011 Jul 15. doi: 10.1002/cncr.26346.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. GANAI S , Winchester DJ
    Screening mammography: bringing back into focus the value of a lifesaving intervention.
    Cancer. 2011;117:3062-3.
    PubMed     Text format     Related articles   
    
    
    
    
79. MELHEM-BERTRANDT A , Bojadzieva J, Ready KJ, Obeid E, et al
    Early onset HER2-positive breast cancer is associated with germline TP53 mutations.
    Cancer. 2011 Jul 14. doi: 10.1002/cncr.26377.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. TAUNK NK , Goyal S, Wu H, Moran MS, et al
    DEAD box 1 (DDX1) expression predicts for local control and overall survival in early stage, node-negative breast cancer.
    Cancer. 2011 Jul 14. doi: 10.1002/cncr.26352.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. KRIEGE M , Jager A, Hooning MJ, Huijskens E, et al
    The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers.
    Cancer. 2011 Jul 14. doi: 10.1002/cncr.26351.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. EDWARDS-BENNETT S
    Receipt of adjuvant breast cancer therapy in minority women: The Type of Treatment Center Matters.
    Cancer. 2011 Jul 12. doi: 10.1002/cncr.26326.
    PubMed     Text format     Related articles   
    
    
    
    
83. FREEDMAN RA , Keating NL
    Reply to receipt of adjuvant breast cancer therapy in minority women.
    Cancer. 2011 Jul 12. doi: 10.1002/cncr.26322.
    PubMed     Text format     Related articles   
    
    
    
    
84. DONOVAN KA , Boyington AR, Ismail-Khan R, Wyman JF, et al
    Urinary symptoms in breast cancer: A Systematic Review.
    Cancer. 2011 Jul 12. doi: 10.1002/cncr.26324.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. HAN W , Kim KY, Yang SJ, Noh DY, et al
    SNP-SNP interactions between DNA repair genes were associated with breast cancer risk in a Korean population.
    Cancer. 2011 Jul 12. doi: 10.1002/cncr.26220.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. WU ZS , Wu Q, Wang CQ, Wang XN, et al
    miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met.
    Cancer. 2011;117:2842-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. PRINTZ C
    Smoking studies produce new findings regarding breast and lung cancer link.
    Cancer. 2011;117:2828-9.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
88. LLOMBART-CUSSAC A , Ruiz A, Anton A, Barnadas A, et al
    Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial.
    Cancer. 2011 Jun 29. doi: 10.1002/cncr.26299.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. HALL C , Krishnamurthy S, Lodhi A, Bhattacharyya A, et al
    Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer.
    Cancer. 2011 Jun 29. doi: 10.1002/cncr.26202.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. GONG Y , Huo L, Liu P, Sneige N, et al
    Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome.
    Cancer. 2011 Jun 28. doi: 10.1002/cncr.26179.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. MARTINEZ SR , Tseng WH, Canter RJ, Chen AM, et al
    Do radiation use disparities influence survival in patients with advanced breast cancer?
    Cancer. 2011 Jun 20. doi: 10.1002/cncr.26231.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. ANDIC F , Godette K, O'Regan R, Zelnak A, et al
    Treatment adherence and outcome in women with inflammatory breast cancer: Does Race Matter?
    Cancer. 2011 Jun 20. doi: 10.1002/cncr.26187.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. MCARTHUR HL , Mahoney KM, Morris PG, Patil S, et al
    Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer.
    Cancer. 2011 Jun 16. doi: 10.1002/cncr.26171.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. AMIRIKIA KC , Mills P, Bush J, Newman LA, et al
    Higher population-based incidence rates of triple-negative breast cancer among young African-American women : Implications for breast cancer screening recommendations.
    Cancer. 2011;117:2747-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. HILL EK , Sandbo S, Abramsohn E, Makelarski J, et al
    Assessing gynecologic and breast cancer survivors' sexual health care needs.
    Cancer. 2011;117:2643-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. DRAGUN AE , Huang B, Tucker TC, Spanos WJ, et al
    Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer: Impact on overall survival.
    Cancer. 2011;117:2590-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. WESTIN SN , Sun CC, Lu KH, Schmeler KM, et al
    Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma.
    Cancer. 2011;117:2659-67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
98. SEXTON KR , Franzini L, Day RS, Brewster A, et al
    A review of body size and breast cancer risk in Hispanic and African American women.
    Cancer. 2011 May 19. doi: 10.1002/cncr.26217.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. COREY-LISLE PK , Peck R, Mukhopadhyay P, Orsini L, et al
    Q-TWiST analysis of ixabepilone in combination with capecitabine on quality of life in patients with metastatic breast cancer.
    Cancer. 2011 May 19. doi: 10.1002/cncr.26213.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. MONTEMURRO F , Rossi V, Rocca MC, Martinello R, et al
     Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patients.
     Cancer. 2011 May 19. doi: 10.1002/cncr.26162.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. CHAVEZ-MACGREGOR M , Brown E, Lei X, Litton J, et al
     Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer.
     Cancer. 2011 May 16. doi: 10.1002/cncr.26144.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. BREEN N , Gentleman JF, Schiller JS
     Update on mammography trends: comparisons of rates in 2000, 2005, and 2008.
     Cancer. 2011;117:2209-18.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. PANET-RAYMOND V , Truong PT, Alexander C, Lesperance M, et al
     Clinicopathologic factors of the recurrent tumor predict outcome in patients with ipsilateral breast tumor recurrence.
     Cancer. 2011;117:2035-43.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. FANG M , Toher J, Morgan M, Davison J, et al
     Genomic differences between estrogen receptor (ER)-positive and ER-negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis.
     Cancer. 2011;117:2024-34.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. NEWCOMB PA , Trentham-Dietz A, Hampton JM, Egan KM, et al
     Late age at first full term birth is strongly associated with lobular breast cancer.
     Cancer. 2011;117:1946-1956.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. MUSOLINO A , Ciccolallo L, Panebianco M, Fontana E, et al
     Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: Epidemiological and clinical data from a population-based cancer registry study.
     Cancer. 2011;117:1837-46.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. DAWOOD S , Ueno NT, Valero V, Woodward WA, et al
     Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: A large population-based study.
     Cancer. 2011;117:1819-26.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. BORDELEAU L , Lipscombe L, Lubinski J, Ghadirian P, et al
     Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations.
     Cancer. 2011;117:1812-1818.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2011
109. BAENA-CANADA JM , Estalella S, Rosado P
     Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer.
     Cancer. 2011;117:1783.
     PubMed     Text format     Related articles   
     
     
     
     
110. DOMINICI LS , Mittendorf EA, Kuerer HM
     Reply to Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer.
     Cancer. 2011;117:1783-4.
     PubMed     Text format     Related articles   
     
     
     
     
111. CHAMPION L , Brain E, Giraudet AL, Le Stanc E, et al
     Breast cancer recurrence diagnosis suspected on tumor marker rising: Value of whole-body 18FDG-PET/CT imaging and impact on patient management.
     Cancer. 2011;117:1621-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. ANDERS CK , Deal AM, Miller CR, Khorram C, et al
     The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
     Cancer. 2011;117:1602-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. ALBERT JM , Gonzalez-Angulo AM, Guray M, Sahin A, et al
     Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer.
     Cancer. 2011;117:1595-601.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. KAUFMANN M , Pusztai L
     Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert Panel.
     Cancer. 2011;117:1575-1582.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. PRINTZ C
     "Stand up to cancer" focuses on accelerating promising research: campaign has raised approximately $180 million.
     Cancer. 2011;117:1557-9.
     PubMed     Text format     Related articles   
     
     
     
     
116. SCHOVER LR , Rhodes MM, Baum G, Adams JH, et al
     Sisters Peer Counseling in Reproductive Issues After Treatment (SPIRIT): A peer counseling program to improve reproductive health among african-american breast cancer survivors.
     Cancer. 2011 Apr 14. doi: 10.1002/cncr.26139.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. SPRAGUE BL , Trentham-Dietz A, Gangnon RE, Ramchandani R, et al
     Socioeconomic status and survival after an invasive breast cancer diagnosis.
     Cancer. 2011;117:1542-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. SMALL BJ , Rawson KS, Walsh E, Jim HS, et al
     Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors.
     Cancer. 2011;117:1369-76.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. MULLIGAN AM , Pinnaduwage D, Bane AL, Bull SB, et al
     CK8/18 expression, the basal phenotype, and family history in identifying BRCA1-associated breast cancer in the Ontario site of the Breast Cancer Family Registry.
     Cancer. 2011;117:1350-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. LECHNER MG , Lade S, Liebertz DJ, Prince HM, et al
     Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: Establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity.
     Cancer. 2011;117:1478-89.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. NAGTEGAAL ID , Allgood PC, Duffy SW, Kearins O, et al
     Prognosis and pathology of screen-detected carcinomas: how different are they?
     Cancer. 2011;117:1360-8.
     PubMed     Text format     Related articles   
     
     
     
     March 2011
122. LIPTON A , Leitzel K, Ali SM, Carney W, et al
     Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy.
     Cancer. 2011 Mar 31. doi: 10.1002/cncr.26101.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. MAZUREK N , Byrd JC, Sun Y, Ueno S, et al
     A galectin-3 sequence polymorphism confers TRAIL sensitivity to human breast cancer cells.
     Cancer. 2011 Mar 28. doi: 10.1002/cncr.26078.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. JANZ NK , Hawley ST, Mujahid MS, Griggs JJ, et al
     Correlates of worry about recurrence in a multiethnic population-based sample of women with breast cancer.
     Cancer. 2011 Mar 28. doi: 10.1002/cncr.25740.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. PECHA V , Kolarik D, Kozevnikova R, Hovorkova K, et al
     Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.
     Cancer. 2011 Mar 22. doi: 10.1002/cncr.26102.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. KUO JF , Lin WL, Han CP
     Reply to detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
     Cancer. 2011 Mar 22. doi: 10.1002/cncr.26092.
     PubMed     Text format     Related articles   
     
     
     
     
127. KUO JF , Lin WL
     Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
     Cancer. 2011 Mar 22. doi: 10.1002/cncr.26089.
     PubMed     Text format     Related articles   
     
     
     
     
128. OSAKO T , Iwase T, Kimura K, Yamashita K, et al
     Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: A comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology.
     Cancer. 2011 Mar 22. doi: 10.1002/cncr.26060.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
129. UCHINO K , Tateishi R, Shiina S, Kanda M, et al
     Hepatocellular carcinoma with extrahepatic metastasis: Clinical features and prognostic factors.
     Cancer. 2011 Mar 22. doi: 10.1002/cncr.25960.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. ERINJERI JP , Fong AJ, Kemeny NE, Brown KT, et al
     Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement.
     Cancer. 2011;117:1296-301.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
131. MOTWANI SB , Goyal S, Moran MS, Chhabra A, et al
     Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194.
     Cancer. 2011;117:1156-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. GOYAL S , Vicini F, Beitsch PD, Kuerer H, et al
     Ductal carcinoma in situ treated with breast-conserving surgery and accelerated partial breast irradiation: comparison of the Mammosite registry trial with intergroup study E5194.
     Cancer. 2011;117:1149-55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
133. NOAH-VANHOUCKE J , Green LE, Dinh TA, Alperin P, et al
     Cost-effectiveness of chemoprevention of breast cancer using tamoxifen in a postmenopausal US population.
     Cancer. 2011 Mar 14. doi: 10.1002/cncr.25926.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2011
134. CHAVEZ-MACGREGOR M , Zhao H, Fang S, Srokowski TP, et al
     Complications associated with erythropoietin-stimulating agents in patients with metastatic breast cancer: A Surveillance, Epidemiology, and End Results-Medicare Study.
     Cancer. 2011 Feb 24. doi: 10.1002/cncr.25972.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: